PTGX FDA Approves Mimrylo (Rusfertide), First Hepcidin Mimetic for Polycythemia Vera The FDA has cleared Mimrylo (rusfertide) for adults with polycythemia vera, calling it the first drug of its kind for the rare blood disorder.
